DAB

Start-up Profile

Founded: 2012

Country: Netherlands

Number of employees: 13

Investors:

  • FORWARD.one
  • InvestNL
  • InnovationQuarter
  • Nemho
  • Delft Enterprises

Main focus areas/active in: 

  • Biorefinery / Pilot Plant
  • Engineering / Scale-up
  • Production Processes / Manufacturing

About: 

DAB – Delft Advanced Biorenewables B.V. – develops, uses and markets advanced fermentation technology. The spin-out from Delft University of Technology has developed the game-changing FAST platform: Fermentation Accelerated by Separation Technology. This advanced fermentation technology is based on the in-situ product removal technique, offering fermentation and separation in a single vessel.

Website: https://dab.bio/

Follow us:

Which input provides your business model/core technology towards a bio-based economy?

DABs FAST platform reduces fermentation product costs by 20-50+%. Large scale FAST deployment – by DAB directly and through out-licensing the technology – will accelerate the replacement of non-renewable compounds, and alleviate many of the supply-side concerns of the chemical formulators (high costs and limited scaled options) and initiate a sustainable, robust supply system of biobased chemicals.

Which market/clients do you address and which short-/long-term goals do you have?

FAST is relevant for strain developers and bio-manufacturers. Strain developers can alleviate product toxicity, making existing pathways more cost effective, or unlock previously inaccessible ones. Biomanufacturers can reduce the costs of existing bioprocesses. Short-term goals are scaling to TRL8 in 2022. Long term goal is to enable a cost-effective bioeconomy through deployment of FAST.

What makes your approach unique compared to other stakeholders in this field?

The FAST platform is a bioreactor design with integrated addition and removal of a secondary layer during fermentation, enabling continuous recovery of product. This secondary layer can be the product (oily products) or an extractive layer (extraction fermentation). The technology is protected by 3 patent applications, is robust, built on proven chemical engineering principles, and close to TRL 8.

Get in touch!

Kirsten Steinbusch
CTO

Please fill out the form below to get in touch with us.